Covishield could cause blood clots in very rare cases, manufacturer AstraZeneca has said. What does this mean?
Global pharmaceutical giant AstraZeneca has said that its AZD1222 vaccine against Covid-19, which was made under licence in India as Covishield, could cause low platelet counts and formation of blood clots in “very rare” cases.AstraZeneca has accepted a …